Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across ...

For the third quarter, the stent maker forecast earnings in a range between 44 cents and 46 cents a share on sales growth of about 17%-to-19%. On an adjusted basis, Boston Sci targeted earnings ...

Check out our 544293 stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

These include Arizona, which is home to the Ventana tissue diagnostics R&D site in Tucson, as well as centers in Indiana and California.

Without scientist Kseniia Petrova’s expertise, no one can fully unlock the data’s potential, putting crucial advancements in early cancer detection at risk.

The former CEO and two other high-ranking executives for Massachusetts-based Magellan Diagnostics have pleaded guilty to criminal charges related to the company’s lead-testing devices that produced ...

The former CEO of Magellan Diagnostics pleaded guilty on Monday to a criminal charge related to a malfunction in the company's lead-testing devices that produced inaccurately low results for tens ...

Local News A ‘mini Mass. and Cass’ on the Common? Boston leaders convene to chart path forward When the Wu administration cleared an encampment near Mass. and Cass, other areas of Boston saw a ...

The paper highlights key considerations and strategic recommendations to improve the development of companion diagnostic tests for rare biomarkers and conditions to enhance patient outcomes.

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate suspected Alzheimer’s disease.